Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 97 | 2,414 | 3,647 | 3,113 | 2,009 |
| Cost of Goods | N/A | 2,334 | 3,552 | 3,006 | 1,873 |
| Gross Profit | 97 | 80 | 95 | 107 | 136 |
| Operating Expenses | 18,755 | 17,815 | 17,197 | 14,864 | 14,497 |
| Operating Income | -18,658 | -17,401 | -16,550 | -14,751 | -13,488 |
| Interest Expense | 519 | 310 | 351 | 381 | 411 |
| Other Income | 161 | 379 | 94 | 105 | 126 |
| Pre-tax Income | -19,016 | -17,332 | -16,807 | -15,027 | -13,773 |
| Net Income Continuous | -19,016 | -17,332 | -16,807 | -15,027 | -13,773 |
| Net Income | $-19,016 | $-17,332 | $-16,807 | $-15,027 | $-13,773 |
| EPS Basic Total Ops | -3.60 | -3.45 | -4.05 | -3.75 | -3.45 |
| EPS Basic Continuous Ops | -3.52 | -3.51 | -4.01 | -3.79 | -3.52 |
| EPS Diluted Total Ops | -3.60 | -3.45 | -4.05 | -3.75 | -3.45 |
| EPS Diluted Continuous Ops | -3.52 | -3.51 | -4.01 | -3.79 | -3.52 |
| EBITDA(a) | $-18,909 | $-17,649 | $-16,065 | $-14,258 | $-12,451 |